Sunday, 26 July 2009

Kalmalin




Kalmalin may be available in the countries listed below.


Ingredient matches for Kalmalin



Lorazepam

Lorazepam is reported as an ingredient of Kalmalin in the following countries:


  • Argentina

International Drug Name Search

Mucosta




Mucosta may be available in the countries listed below.


Ingredient matches for Mucosta



Rebamipide

Rebamipide is reported as an ingredient of Mucosta in the following countries:


  • China

  • Indonesia

  • Japan

  • Philippines

  • Thailand

  • Vietnam

International Drug Name Search

Thursday, 23 July 2009

Respigam injectable


Generic Name: respiratory syncytial virus immune globulin (RSV IG) (injectable) (RES pir tory SIN sih shull VYE rus ih MUNE GLAW byoo lin)

Brand Names: Respigam


What is RSV IG?

Respiratory syncytial virus immune globulin (RSV IG) is a sterilized solution obtained from pooled human blood. It contains the immunoglobulins (or antibodies) to protect against infection from respiratory syncytial virus (RSV), a virus that can cause serious illness in children. Antibodies are substances in the blood that fight infections.


RSV IG is used to help prevent or reduce the severity of lower respiratory tract (lung) disease caused by respiratory syncytial virus in children who are at increased risk.


RSV IG may also be used for purposes other than those listed here.


What is the most important information I should know about RSV IG?


RSV IG is made from human plasma (part of the blood) and may contain infectious agents (e.g., viruses) that can cause disease. Although RSV IG is screened, tested, and treated to reduce the possibility that it carries an infectious agent, it can still potentially transmit disease. Discuss with the doctor the risks and benefits of using RSV IG.


Treatment with immune globulin products such as RSV IG has been associated with the development of kidney problems, sometimes resulting in kidney failure and/or death. Notify the doctor immediately if symptoms such as decreased urination, sudden weight gain, fluid retention or swelling, or shortness of breath occur. These may be signs of kidney problems. Rare cases of aseptic meningitis syndrome (AMS) have been associated with the use of immune globulin products such as RSV IG. Notify the doctor immediately if symptoms such as severe headache, neck stiffness, drowsiness, fever, eye sensitivity to light, painful eye movements, and nausea or vomiting occur. These may be signs of AMS. Stopping treatment with the immune globulin has resulted in resolution of AMS without any lasting problems.

What should I discuss with my healthcare provider before using RSV IG?


Do not use RSV IG without first talking to your doctor if you have

  • kidney disease;




  • diabetes;




  • IgA deficiency; or




  • had a previous allergic reaction to an immune globulin product.



You may not be able to use RSV IG, or you may require a dosage adjustment or special monitoring during treatment.


RSV IG is in the FDA pregnancy category C. This means that it is not known whether it will be harmful to an unborn baby. Do not use RSV IG without first talking to your doctor if you are pregnant or could become pregnant during treatment. It is not known whether RSV IG passes into breast milk. Do not use RSV IG without first talking to your doctor if you are breast-feeding a baby.

How should I take RSV IG?


RSV IG will be administered by intravenous (into a vein) injection by a healthcare provider in a hospital or clinic setting. If RSV IG is being administered at home, your healthcare provider will give you detailed instructions regarding administration.


RSV IG is usually administered once a month during the RSV season. Your healthcare provider will give you detailed instructions on when the medication should be administered.


Your doctor may want to perform monitoring during treatment with RSV IG to monitor progress and side effects.


Your healthcare provider will store RSV IG as directed by the manufacturer. If RSV IG is being stored at home, your healthcare provider will give you storage instructions.


What happens if I miss a dose?


Contact your healthcare provider if a dose of RSV IG is missed.


What happens if I overdose?


Seek emergency medical attention or contact your healthcare provider if an overdose of RSV IG is suspected.

No information is available regarding an overdose of RSV IG.


What should I avoid while taking RSV IG?


Vaccinations that use live strains of the virus (e.g., measles, mumps, and rubella or MMR) given during and for approximately ten months following treatment with RSV IG may not produce the desired response. Additional doses of the vaccine may be necessary to ensure effectiveness.

RSV IG side effects


RSV IG is made from human plasma (part of the blood) and may contain infectious agents (e.g., viruses) that can cause disease. Although RSV IG is screened, tested, and treated to reduce the possibility that it carries an infectious agent, it can still potentially transmit disease. Discuss with the doctor the risks and benefits of using RSV IG.


Treatment with immune globulin products such as RSV IG has been associated with the development of kidney problems, sometimes resulting in kidney failure and/or death. Notify the doctor immediately if symptoms such as decreased urination, sudden weight gain, fluid retention or swelling, or shortness of breath occur. These may be signs of kidney problems. Rare cases of aseptic meningitis syndrome (AMS) have been associated with the use of immune globulin products such as RSV IG. Notify the doctor immediately if symptoms such as severe headache, neck stiffness, drowsiness, fever, eye sensitivity to light, painful eye movements, and nausea or vomiting occur. These may be signs of AMS. Stopping treatment with the immune globulin has resulted in resolution of AMS without any lasting problems. Notify your doctor immediately if a rare but serious allergic reaction (difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives) to RSV IG is experienced.

Other less serious side effects may also occur. Upon injection of the medication, some patients may experience the following side effects:



  • fever;




  • vomiting;




  • diarrhea; or




  • rash.



Side effects other than those listed here may also occur. Talk to your doctor about any side effect that seems unusual or that is especially bothersome.


What other drugs will affect RSV IG?


Vaccinations that use live strains of the virus (e.g., measles, mumps, and rubella or MMR) given during and for approximately ten months following treatment with RSV IG may not produce the desired response. Additional doses of the vaccine may be necessary to ensure effectiveness.

It is not known whether other medications will interact with RSV IG. Talk to your doctor and pharmacist before taking any prescription or over-the-counter medicines, including herbal products during treatment with RSV IG.



More Respigam resources


  • Respigam Side Effects (in more detail)
  • Respigam Use in Pregnancy & Breastfeeding
  • Respigam Drug Interactions
  • Respigam Support Group
  • 0 Reviews for Respigam - Add your own review/rating


Compare Respigam with other medications


  • Respiratory Syncytial Virus


Where can I get more information?


  • Your pharmacist has additional information about RSV IG written for health professionals that you may read.

What does my medication look like?


RSV IG is available with a prescription under the brand name Respigam. Other brand or generic formulations may also be available. Ask your pharmacist any questions you have about this medication, especially if it is new to you.


See also: Respigam side effects (in more detail)


Wednesday, 22 July 2009

Sovipan




Sovipan may be available in the countries listed below.


Ingredient matches for Sovipan



Aceclofenac

Aceclofenac is reported as an ingredient of Sovipan in the following countries:


  • Greece

International Drug Name Search

Arelix ACE




Arelix ACE may be available in the countries listed below.


Ingredient matches for Arelix ACE



Piretanide

Piretanide is reported as an ingredient of Arelix ACE in the following countries:


  • Germany

Ramipril

Ramipril is reported as an ingredient of Arelix ACE in the following countries:


  • Germany

International Drug Name Search

Thursday, 16 July 2009

Davixolol




Davixolol may be available in the countries listed below.


Ingredient matches for Davixolol



Betaxolol

Betaxolol is reported as an ingredient of Davixolol in the following countries:


  • Portugal

International Drug Name Search

Tuesday, 14 July 2009

Irunine




Irunine may be available in the countries listed below.


Ingredient matches for Irunine



Itraconazole

Itraconazole is reported as an ingredient of Irunine in the following countries:


  • Russian Federation

International Drug Name Search

Sunday, 12 July 2009

Ketokonazol Alternova




Ketokonazol Alternova may be available in the countries listed below.


Ingredient matches for Ketokonazol Alternova



Ketoconazole

Ketoconazole is reported as an ingredient of Ketokonazol Alternova in the following countries:


  • Sweden

International Drug Name Search

Friday, 10 July 2009

Gabapentine




Gabapentine may be available in the countries listed below.


Ingredient matches for Gabapentine



Gabapentin

Gabapentine (DCF) is known as Gabapentin in the US.

International Drug Name Search

Glossary

DCFDénomination Commune Française

Click for further information on drug naming conventions and International Nonproprietary Names.

Thursday, 9 July 2009

Depo-Medrol


Depo-Medrol is a brand name of methylprednisolone, approved by the FDA in the following formulation(s):


DEPO-MEDROL (methylprednisolone acetate - injectable; injection)



  • Manufacturer: PHARMACIA AND UPJOHN

    Approved Prior to Jan 1, 1982

    Strength(s): 20MG/ML [RLD], 40MG/ML [RLD][AB], 80MG/ML [RLD][AB]

Has a generic version of Depo-Medrol been approved?


Yes. The following products are equivalent to Depo-Medrol:


methylprednisolone acetate injectable; injection



  • Manufacturer: SANDOZ

    Approval date: January 29, 2009

    Strength(s): 40MG/ML [AB], 80MG/ML [AB]


  • Manufacturer: SANDOZ

    Approval date: March 5, 2009

    Strength(s): 40MG/ML [AB], 80MG/ML [AB]


  • Manufacturer: TEVA PARENTERAL

    Approval date: February 23, 2005

    Strength(s): 40MG/ML [AB], 80MG/ML [AB]


  • Manufacturer: TEVA PARENTERAL

    Approval date: October 27, 2006

    Strength(s): 40MG/ML [AB], 80MG/ML [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Depo-Medrol. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Depo-Medrol.

See also...

  • Depo-Medrol Suspension Consumer Information (Wolters Kluwer)
  • Methylprednisolone Consumer Information (Drugs.com)
  • Methylprednisolone Consumer Information (Wolters Kluwer)
  • Methylprednisolone Solution Consumer Information (Wolters Kluwer)
  • Methylprednisolone Suspension Consumer Information (Wolters Kluwer)
  • Methylprednisolone Consumer Information (Cerner Multum)
  • Methylprednisolone AHFS DI Monographs (ASHP)
  • Methylprednisolone Acetate AHFS DI Monographs (ASHP)
  • Methylprednisolone Sodium Succinate AHFS DI Monographs (ASHP)

Monday, 6 July 2009

Dynacil comp




Dynacil comp may be available in the countries listed below.


Ingredient matches for Dynacil comp



Fosinopril

Fosinopril sodium salt (a derivative of Fosinopril) is reported as an ingredient of Dynacil comp in the following countries:


  • Germany

Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Dynacil comp in the following countries:


  • Germany

International Drug Name Search

Friday, 3 July 2009

Fosfocin




Fosfocin may be available in the countries listed below.


Ingredient matches for Fosfocin



Fosfomycin

Fosfomycin calcium salt (a derivative of Fosfomycin) is reported as an ingredient of Fosfocin in the following countries:


  • Italy

Fosfomycin disodium salt (a derivative of Fosfomycin) is reported as an ingredient of Fosfocin in the following countries:


  • Italy

International Drug Name Search